Literature DB >> 11001797

Genetic determinants of Graves disease.

D A Chistyakov1, K V Savost'anov, R I Turakulov, V V Nosikov.   

Abstract

Basedow-Graves disease is an autoimmune thyroid syndrome. Genetic factors contribute to the pathogenesis of Graves disease, and current findings confirm that a number of genes may be involved in the development of autoimmune thyrotoxicosis. At present three loci, namely human leukocyte antigen (HLA, 6p21.3), cytotoxic T-lymphocyte-associated esterase-4 (CTLA4, 2q33), and thyroid-stimulating hormone receptor (TSHR, 14q31), are the only well-known genetic determinants for Graves disease. It is difficult to determine clearly the contribution of large multifunctional proteasome genes and transporter genes associated with antigen processing in the disorder, because of strong linkage disequilibrium between these genes and certain HLA alleles. Two recently discovered suspectibility loci, 20q11.2 and Xq21.33-q22, should be studied to find specific genes linked to Graves disease. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001797     DOI: 10.1006/mgme.2000.3042

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  3 in total

1.  Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.

Authors:  Tatjana Sjakste; Jelena Eglite; Arturs Sochnevs; Mara Marga; Valdis Pirags; Yrjö Collan; Nikolajs Sjakste
Journal:  Immunogenetics       Date:  2004-06-17       Impact factor: 2.846

2.  Total thyroidectomy in Basedow-Graves' disease treatment: our experience.

Authors:  M Barbuscia; A Querci; A Tonante; D Paparo; F Taranto; A Ilacqua; E Gagliano; A Milone
Journal:  G Chir       Date:  2015 May-Jun

3.  Graves' ophthalmopathy: a review of immunogenetics.

Authors:  Omid Khalilzadeh; Sina Noshad; Armin Rashidi; Aliakbar Amirzargar
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.